Global Pharmaceutical Contract Manufacturing and Contract Market Size, Status and Forecast 2020-2026
Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
North America is the largest consumption place, with a consumption market share nearly 35% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.
Market Analysis and Insights: Global Pharmaceutical Contract Manufacturing and Contract Market
In 2019, the global Pharmaceutical Contract Manufacturing and Contract market size was US$ 77210 million and it is expected to reach US$ 119770 million by the end of 2026, with a CAGR of 6.4% during 2021-2026.
Global Pharmaceutical Contract Manufacturing and Contract Scope and Market Size
Pharmaceutical Contract Manufacturing and Contract market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Contract Manufacturing and Contract market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Pharmaceutical Contract Manufacturing and Contract market is segmented into Oral, Injectable, API, Other, etc.
Segment by Application, the Pharmaceutical Contract Manufacturing and Contract market is segmented into Small Medium Enterprise, Large Enterprise, etc.
Regional and Country-level Analysis
The Pharmaceutical Contract Manufacturing and Contract market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pharmaceutical Contract Manufacturing and Contract market report are North America, Europe, China, Japan, Southeast Asia and India, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Pharmaceutical Contract Manufacturing and Contract market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Pharmaceutical Contract Manufacturing and Contract business, the date to enter into the Pharmaceutical Contract Manufacturing and Contract market, Pharmaceutical Contract Manufacturing and Contract product introduction, recent developments, etc.
The major vendors include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, Recipharm, Aenova, AbbVie, Baxter, Nipro Corp, Sopharma, Famar, Vetter, Shandong Xinhua, Piramal, Mylan, Dr. Reddy’s, Zhejiang Hisun, Zhejiang Huahai, Jubilant, etc.
This report focuses on the global Pharmaceutical Contract Manufacturing and Contract status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical Contract Manufacturing and Contract development in North America, Europe, China, Japan, Southeast Asia and India.
Catalent
Thermo Fisher Scientific
Lonza
Boehringer Ingelheim
Fareva
Recipharm
Aenova
AbbVie
Baxter
Nipro Corp
Sopharma
Famar
Vetter
Shandong Xinhua
Piramal
Mylan
Dr. Reddy’s
Zhejiang Hisun
Zhejiang Huahai
Jubilant
Oral
Injectable
API
Other
The proportion of API Manufacturing in 2018 is about 73%, and the proportion is in decreasing trend from 2014 to 2018. However, the Injectable segment is the fastest growing segment.
Small Medium Enterprise
Large Enterprise
The most proportion of pharmaceutical contract manufacturing & contract is used for Large Enterprise, and the proportion in 2018 is 60%.
North America
Europe
China
Japan
Southeast Asia
India
To analyze global Pharmaceutical Contract Manufacturing and Contract status, future forecast, growth opportunity, key market and key players.
To present the Pharmaceutical Contract Manufacturing and Contract development in North America, Europe, China, Japan, Southeast Asia and India.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Pharmaceutical Contract Manufacturing and Contract are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
North America is the largest consumption place, with a consumption market share nearly 35% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.
Market Analysis and Insights: Global Pharmaceutical Contract Manufacturing and Contract Market
In 2019, the global Pharmaceutical Contract Manufacturing and Contract market size was US$ 77210 million and it is expected to reach US$ 119770 million by the end of 2026, with a CAGR of 6.4% during 2021-2026.
Global Pharmaceutical Contract Manufacturing and Contract Scope and Market Size
Pharmaceutical Contract Manufacturing and Contract market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Contract Manufacturing and Contract market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Pharmaceutical Contract Manufacturing and Contract market is segmented into Oral, Injectable, API, Other, etc.
Segment by Application, the Pharmaceutical Contract Manufacturing and Contract market is segmented into Small Medium Enterprise, Large Enterprise, etc.
Regional and Country-level Analysis
The Pharmaceutical Contract Manufacturing and Contract market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pharmaceutical Contract Manufacturing and Contract market report are North America, Europe, China, Japan, Southeast Asia and India, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Pharmaceutical Contract Manufacturing and Contract Market Share AnalysisPharmaceutical Contract Manufacturing and Contract market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Pharmaceutical Contract Manufacturing and Contract business, the date to enter into the Pharmaceutical Contract Manufacturing and Contract market, Pharmaceutical Contract Manufacturing and Contract product introduction, recent developments, etc.
The major vendors include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, Recipharm, Aenova, AbbVie, Baxter, Nipro Corp, Sopharma, Famar, Vetter, Shandong Xinhua, Piramal, Mylan, Dr. Reddy’s, Zhejiang Hisun, Zhejiang Huahai, Jubilant, etc.
This report focuses on the global Pharmaceutical Contract Manufacturing and Contract status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutical Contract Manufacturing and Contract development in North America, Europe, China, Japan, Southeast Asia and India.
The key players covered in this study
Catalent
Thermo Fisher Scientific
Lonza
Boehringer Ingelheim
Fareva
Recipharm
Aenova
AbbVie
Baxter
Nipro Corp
Sopharma
Famar
Vetter
Shandong Xinhua
Piramal
Mylan
Dr. Reddy’s
Zhejiang Hisun
Zhejiang Huahai
Jubilant
Market segment by Type, the product can be split into
Oral
Injectable
API
Other
The proportion of API Manufacturing in 2018 is about 73%, and the proportion is in decreasing trend from 2014 to 2018. However, the Injectable segment is the fastest growing segment.
Market segment by Application, split into
Small Medium Enterprise
Large Enterprise
The most proportion of pharmaceutical contract manufacturing & contract is used for Large Enterprise, and the proportion in 2018 is 60%.
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
The study objectives of this report are:
To analyze global Pharmaceutical Contract Manufacturing and Contract status, future forecast, growth opportunity, key market and key players.
To present the Pharmaceutical Contract Manufacturing and Contract development in North America, Europe, China, Japan, Southeast Asia and India.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Pharmaceutical Contract Manufacturing and Contract are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
